【适应证】需要长期奥曲肽治疗的活动性肢端肥大症，如术后生长激素残瘤致血清生长激素水平增高，垂体外照射放射治疗后尚未达到充分疗效的血清生长激素水平升高，部分不适合手术治疗及新诊断生长激素分泌腺瘤患者的术前治疗。 【药品分类】内分泌系统用药-下丘脑垂体激素与相关药物-生长素释放抑制激素类似物
注射用醋酸奥曲肽微球 Sandostatin LAR ; Octreotide Acetate Microspheres for Injection ; Octreotide Acetate Microspheres fo ; Octreotide Acetate Mi
醋酸奥曲肽注射液 Octreotide Acetate Injection ; Sandostatin ; OctreotideAceta
注射用醋酸奥曲肽 Octreotide Acetate for Injection ; Octreotide Acetate Injection
Methods Totally 31 patients with grade 3 diarrhea were administered with octreotide acetate (100μg,s. c,tid). Clinical condition,times of diarrhea,and side effects were recorded.
方法选择发生化疗相关性腹泻的肿瘤患者31例,给予醋酸奥曲肽100μg肌肉注射,3次/日治疗,记录患者一般状况、腹泻次数及用药反应。
参考来源 - 醋酸奥曲肽治疗化疗相关性腹泻疗效观察·2,447,543篇论文数据，部分数据来源于NoteExpress
建立首批醋酸奥曲肽的国家对照品。
目的设计并合成醋酸奥曲肽。
目的：评价国产醋酸奥曲肽注射液治疗食管-胃底静脉曲张破裂出血的疗效和安全性。
Objective: To evaluate the efficacy and safety of domestic octreotide for injection in the treatment of acute esophageal and gastric variceal bleeding.
应用推荐